AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Webcast First Quarter Results and Morgan Stanley Global Healthcare Unplugged Conference Presentation SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast its Quarterly Update Conference Call for the first quarter of 2005 on Wednesday, May 4, 2005 at 12:00 p.m. ET/9:00 a.m. PT. The call will be led by Ginger L. Graham, Amylin's President and Chief Executive Officer. On the same date, prior to the market open, Amylin will release financial results for the first quarter ended March 31, 2004. For those without access to the Internet, the live call may be accessed by phone by calling (888) 396-2298 (domestic) or (617) 847-8708 (international), passcode 24262146. A replay of the Quarterly Update Conference Call will also be available by phone for 24 hours beginning approximately one hour after the close of the call and can be accessed at (888) 286-8010 (domestic) or (617) 801-6888 (international), passcode 40550012. Amylin will also be presenting at the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May 5, 2005 at 11:15 a.m. ET/8:15 a.m. PT in Miami. Daniel M. Bradbury, Chief Operating Officer of Amylin Pharmaceuticals, will be providing a corporate overview. Both events will be webcast live, and recordings will be made available. The webcasts and recordings will be accessible through Amylin's corporate website, located at http://www.amylin.com/. To access the live webcasts, please log on to Amylin's site approximately fifteen minutes prior to the events to register and download any necessary audio software. Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive Director, Investor Relations of Amylin Pharmaceuticals, Inc., +1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/

Copyright